{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:14:42Z","timestamp":1781626482582,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3992,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1111\/j.1523-1755.2005.00077.x","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T18:20:18Z","timestamp":1102616418000},"page":"265-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Tazeen H.","family":"Jafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend","family":"Strandgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease","volume":"329","author":"Gabow","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0015","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0025","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"The Gisen Group (Gruppo Italiano Di Studi Epidemiologici In Nefrologia)","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0272-6386(96)90158-4","article-title":"Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trial","volume":"27","author":"Ihle","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/oxfordjournals.qjmed.a030139","article-title":"Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease","volume":"89","author":"Kanno","year":"1996","journal-title":"Q J Med"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(00)70054-0","article-title":"Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury","volume":"35","author":"Ruggenenti","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000046231","article-title":"Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease","volume":"21","author":"Ecder","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(00)70195-8","article-title":"Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease","volume":"35","author":"Ecder","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0055","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/ndt\/gfg417","article-title":"No effect of enalapril on progression in autosomal dominant polycystic kidney disease","volume":"18","author":"Van Dijk","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin converting enzyme inhibitors and progression of non-diabetic renal disease: A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ki.1992.309","article-title":"Long-term comparison between captopril and nifedipine in the progression of renal insufficiency","volume":"42","author":"Zucchelli","year":"1992","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0070","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ajh\/5.7.423","article-title":"Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial","volume":"5","author":"Kamper","year":"1992","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0075","first-page":"S58","article-title":"Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?","volume":"Suppl 63","author":"Van Essen","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.309.6958.833","article-title":"Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure","volume":"309","author":"Hannedouche","year":"1994","journal-title":"Br Med J"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000423895","article-title":"Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy","volume":"111","author":"Bannister","year":"1995","journal-title":"Contrib Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08037059509077575","article-title":"Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy: ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension","volume":"4","author":"Himmelmann","year":"1995","journal-title":"Blood Press"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0197-2456(02)00319-7","article-title":"Constructing a database of individual clinical trials for longitudinal analysis","volume":"24","author":"Schmid","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0105","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1523-1755.2001.0600031131.x","article-title":"Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease","volume":"60","author":"Jafar","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0110","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1681\/ASN.V1091916","article-title":"The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease","volume":"10","author":"Van Dijk","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0115","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1681\/ASN.V661634","article-title":"Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease","volume":"6","author":"Choukroun","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0125","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/bmj.322.7293.1043","article-title":"ABC of hypertension: Blood pressure measurement. Part II. Conventional sphygmomanometry: Technique of auscultatory blood pressure measurement","volume":"322","author":"Beevers","year":"2001","journal-title":"Br Med J"},{"key":"10.1111\/j.1523-1755.2005.00077.x_bb0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815504493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815504493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:45:04Z","timestamp":1758761104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815504493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0085253815504493"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00077.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00077.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}